News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
73,495 Results
Type
Article (1919)
Company Profile (2)
Press Release (71574)
Section
Business (25337)
Career Advice (9)
Deals (4552)
Drug Development (8185)
FDA (1816)
Job Trends (804)
News (37069)
Policy (3569)
Tag
2027 BioCapital Standard (1)
Academia (98)
Accelerated approval (5)
ADA (2)
Allergies (21)
Alliances (8165)
ALS (15)
Alzheimer's disease (184)
Antibody-drug conjugate (ADC) (114)
Approvals (1979)
Artificial intelligence (36)
ASCO (37)
Autoimmune disease (35)
Automation (2)
Bankruptcy (8)
Best Places to Work (590)
BIO (9)
Biosimilars (94)
Biotechnology (5)
Bladder cancer (32)
Brain cancer (8)
Breast cancer (64)
Cancer (653)
Cardiovascular disease (28)
Career advice (9)
CAR-T (16)
CDC (1)
Cell therapy (60)
Cervical cancer (5)
Clinical research (7719)
Collaboration (340)
Commercialization (1)
Compensation (27)
Complete response letters (7)
COVID-19 (199)
CRISPR (1)
C-suite (96)
Cystic fibrosis (8)
Data (850)
Depression (16)
Dermatology (11)
Diabetes (44)
Diagnostics (646)
Digital health (7)
Drug discovery (42)
Drug pricing (1)
Duchenne muscular dystrophy (43)
Earnings (8185)
Events (7620)
Executive appointments (75)
FDA (2333)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (156)
Gene editing (7)
Generative AI (1)
Gene therapy (41)
GLP-1 (81)
Government (242)
Grass and pollen (1)
Guidances (39)
Healthcare (1096)
Hematology (14)
HIV (7)
Huntington's disease (3)
IgA nephropathy (23)
Immunology and inflammation (7)
Immuno-oncology (11)
Indications (28)
Infectious disease (225)
Inflammatory bowel disease (25)
Inflation Reduction Act (1)
Influenza (14)
Intellectual property (41)
IPO (1640)
Job creations (241)
Job search strategy (9)
JPM (3)
Kidney cancer (1)
Layoffs (6)
Legal (953)
Liver cancer (19)
Longevity (3)
Lung cancer (118)
Lymphoma (56)
Machine learning (1)
Manufacturing (131)
Marketing (4)
MASH (19)
Medical device (1174)
Medtech (1192)
Mergers & acquisitions (3112)
Metabolic disorders (113)
mRNA (7)
Multiple sclerosis (25)
NASH (1)
Neurodegenerative disease (35)
Neuropsychiatric disorders (7)
Neuroscience (339)
NextGen: Class of 2026 (218)
Non-profit (64)
Obesity (38)
Opinion (1)
Ovarian cancer (35)
Pain (23)
Pancreatic cancer (31)
Parkinson's disease (49)
Partnered (4)
Patents (76)
Patient recruitment (79)
Peanut (1)
People (5188)
Pharmaceutical (2)
Pharmacy benefit managers (5)
Phase 1 (2082)
Phase 2 (3264)
Phase 3 (2911)
Pipeline (1229)
Policy (2)
Postmarket research (251)
Preclinical (710)
Press Release (2)
Prostate cancer (28)
Radiopharmaceuticals (25)
Rare diseases (85)
Real estate (606)
Regulatory (3061)
Reports (6)
Research institute (97)
Rett syndrome (1)
RNA editing (3)
RSV (3)
Schizophrenia (21)
Series A (32)
Series B (25)
Service/supplier (1)
Sickle cell disease (8)
Spinal muscular atrophy (5)
Sponsored (1)
Startups (424)
Stomach cancer (2)
Supply chain (13)
Vaccines (46)
Venture capital (7)
Weight loss (17)
Women's health (7)
Date
Last 7 days (39)
Last 30 days (181)
Last 365 days (2821)
2026 (1635)
2025 (2704)
2024 (3265)
2023 (3822)
2022 (7006)
2021 (6376)
2020 (5870)
2019 (3865)
2018 (3014)
2017 (3569)
2016 (3180)
2015 (4042)
2014 (3038)
2013 (2601)
2012 (2776)
2011 (2904)
2010 (2663)
Location
Africa (88)
Alabama (4)
Arizona (14)
Arkansas (1)
Asia (22280)
Australia (2485)
California (803)
Canada (469)
China (509)
Colorado (5)
Connecticut (23)
Delaware (6)
Europe (13436)
Florida (88)
Georgia (17)
Illinois (44)
India (53)
Indiana (55)
Japan (340)
Kansas (5)
Louisiana (2)
Maine (4)
Maryland (124)
Massachusetts (638)
Michigan (9)
Minnesota (38)
Missouri (3)
Nebraska (3)
Nevada (10)
New Hampshire (1)
New Jersey (490)
New York (285)
North Carolina (125)
Northern California (341)
Ohio (6)
Oregon (1)
Pennsylvania (151)
Puerto Rico (1)
Rhode Island (1)
South America (109)
South Carolina (1)
Southern California (394)
Tennessee (4)
Texas (61)
United States (3115)
Utah (30)
Vermont (1)
Virginia (63)
Washington D.C. (3)
Washington State (61)
Wisconsin (8)
73,495 Results for "neuraxis ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
NeurAxis, Inc. Announces Preferred Stock Dividend
April 10, 2026
·
3 min read
Press Releases
NeurAxis Reports Record First Quarter 2026 Financial Results Driven by 80% Year Over Year Revenue Growth
May 12, 2026
·
7 min read
Press Releases
NeurAxis to Host First Quarter 2026 Results and Business Update Call on Tuesday, May 12, 2026
May 5, 2026
·
1 min read
Press Releases
NeurAxis Reports Strong Fourth Quarter and Full Year 2025 Financial Results
March 19, 2026
·
10 min read
Press Releases
NeurAxis to Host Fourth Quarter and Full Year 2025 Results and Business Update Call on Thursday, March 19, 2026
March 13, 2026
·
2 min read
Press Releases
NeurAxis Announces New Medical Policy Coverage in Michigan, Adding 566,000 Covered Lives
November 13, 2025
·
4 min read
Press Releases
NeurAxis Reports Strong Third Quarter 2025 Financial Results Driven by a 22% Growth in Revenues
November 12, 2025
·
8 min read
Press Releases
NeurAxis to Host Third Quarter 2025 Results and Business Update Call on Tuesday, November 11, 2025
November 5, 2025
·
3 min read
Press Releases
NeurAxis to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
September 18, 2025
·
3 min read
Press Releases
NeurAxis Awarded First Ever FDA Clearance for the Treatment of Pain in Functional Dyspepsia (FD) with associated Nausea Symptoms in the Adult Patient Population
October 27, 2025
·
4 min read
1 of 7,350
Next
